Femistad

Femistad is a combined oral contraceptive containing Desogestrel and Ethinylestradiol. It is used for birth control and may also help regulate menstrual cycles. This medication is manufactured by Stada Arzneimittel AG in the EU.

Femistad is primarily used for contraception, preventing pregnancy by inhibiting ovulation and altering cervical mucus. It may also be prescribed to manage menstrual irregularities. Desogestrel and Ethinylestradiol work together to provide reliable birth control when taken as directed.

Common effects of Femistad may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, nausea, or headaches. These effects vary and typically subside as the body adjusts to the medication.

Femistad should be used with caution in individuals with a history of blood clots, high blood pressure, or liver disease. Regular medical check-ups are recommended. Always inform your healthcare provider about any pre-existing conditions before starting this medication.

Femistad may interact with certain medications, including antibiotics, anticonvulsants, and HIV protease inhibitors. Alcohol consumption should be moderated, as it may affect the effectiveness of the contraceptive. Always consult a healthcare provider before combining Femistad with other medications.